CSaP is delighted to announce the names of the successful applicants to the Fellowship for Michaelmas Term 2015

On 22 June 2015 the Centre for Science and Policy ran a workshop titled 'Restorative Justice: pathways for the future'. The event was organised in partnership with the Restorative Justice Council, the independent third sector membership body for the field of restorative practice, and the University of Cambridge's Faculty of Education.

The Centre for Science and Policy is delighted to welcome Professor Jatin Nathwani as a Visiting Research Fellow in July 2015.

CSaP's latest Policy Challenge briefing was launched at a major conference in Cambridge this week which brought together researchers, policy makers and industry practitioners to explore the latest developments in the 'Big Data Era'.

Science, technology, engineering and mathematics (STEM) are fields at the heart of innovation and the UK’s economy, yet recent YouGov research shows that, according to both businesses and academics, nearly 60% of employers of STEM graduates think there is a skills gap in Britain.

Professor Szreter used historical cases in Britain to demonstrate how the nature and scale of health inequalities within a society are produced by the social and cultural environment of values and incentives experienced by the rich, as much as by the poor (who are the usual focus of attention).

The eighth meeting of CSaP's Policy Leaders Fellowship focussed on 'Infection', with a talk by Dr Nigel Collier.

Our latest ESRC intern, Nick Jones a PhD student at the Centre for Diet and Activity Research, has written a case study describing his time at CSaP and the experience and new skills he acquired.

Nadia Calviño, European Commission Director-General for Budget, is the latest new recruit to CSaP's Policy Leaders Fellowship.

On 1 May the Centre for Science and Policy hosted a workshop in association with the Centre for Law Medicine and Life Sciences at the University of Cambridge. The overall aim was to identify and discuss key issues in intellectual property (IP) policies and strategies affecting the development of genomic medicine.